Medicure Inc. (CVE:MPH – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$0.88 and traded as low as C$0.79. Medicure shares last traded at C$0.79, with a volume of 1,000 shares changing hands.
Medicure Stock Down 11.2 %
The company has a current ratio of 2.03, a quick ratio of 1.29 and a debt-to-equity ratio of 4.65. The company has a 50-day simple moving average of C$0.80 and a 200 day simple moving average of C$0.88. The company has a market cap of C$8.24 million, a P/E ratio of -4.05 and a beta of 0.90.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What is a Low P/E Ratio and What Does it Tell Investors?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Warren Buffett Stocks to Buy Now
- Top 3 Beverage Stocks Pouring Out Profits
- Russell 2000 Index, How Investors Use it For Profitable Trading
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
